Metformin

BreastfeedingGeriatricPediatric
  • TRADE NAMES: Apo-Metformin; Avandamet (GSK); Diabex; Diaformin; Diformin; Fortamet (Andrx); Gen-Metformin; Glucomet; Glucophage (Merck Serono); Glucovance (Merck Serono); Invokamet (Janssen); Janumet (Merck Sharpe & Dohme); Metaglip; Metforal; Metomin; Novo-Metformin; Riomet; Synjardy (Boehringer Ingelheim); Xigduo XR (AstraZeneca)
  • INDICATIONS: Diabetes
  • CLASS: Antidiabetic, Biguanide, Hypoglycemic (antihyperglycemic) agent
  • HALF-LIFE: 6 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

ACE inhibitors, Acetazolamide, Alcohol, Amiloride, Anabolic steroids, Beta blockers, Bictegravir/Emtricitabine/Tenofovir Alafenamide, Calcium channel blockers, Captopril, Cephalexin, Cilazapril, Cimetidine, Corticosteroids, Diazoxide, Dichlorphenamide, Digoxin, Disopyramide, Diuretics, Enalapril, Estrogens, Fosinopril, Iodinated contrast agents, Isoniazid, Ketotifen, Lanreotide, Lisinopril, Luteinizing hormone releasing hormone analogs, MAO inhibitors, Morphine, Nicotinic acid, Octreotide, Oral Contraceptives, Pegvisomant, Phenothiazines, Phenytoin, Procainamide, Progestogens, Quinapril, Quinidine, Quinine, Ramipril, Ranitidine, Risdiplam, Somatropin, Sotorasib, Sympathomimetics, Testosterone, Thiazides, Thyroid products, Topiramate, Trandolapril, Triamterene, Trilaciclib, Trimethoprim, Trospium, Tucatinib, Vancomycin, Zonisamide

PREGNANCY CATEGORY: B

Lactic acidosis is a rare, but serious, metabolic complication that can occur due to metformin accumulation.

Avandamet is metformin and rosiglitazone; Glucovance is metformin and glyburide; Invokamet is metformin and canagliflozin; Janumet is metformin and sitagliptin; Synjardy is metformin and empagliflozin; Xigduo XR is metformin and dapagliflozin.

LACTIC ACIDOSIS

See full prescribing information for complete boxed warning.

Our database has 101 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN.
HAIR.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
GENITOURINARY.
HEMATOLOGIC.
LOCAL.
NEUROMUSCULAR/SKELETAL.
RENAL.
RESPIRATORY.
OTHER.


Page last updated 11/02/2023

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top